Results of a scientific study indicate birth defects in infants born to women taking antidepressants, including Paxil, during the first trimester of pregnancy. In fact the study revealed a greater risk for women who took Paxil (paroxetine) in the first trimester, as opposed to other antidepressants.

As a result of the study, in September 2005 drug manufacturer GlaxoSmithKline informed health care professionals that it was updating the Pregnancy subsection of the PRECAUTIONS section of the labels for the drug Paxil (paroxetine HCI) and Paxil CR controlled-release tablets to indicate the Paxil side effects.

The study revealed a greater risk for overall birth defects for women using paroxetine, and an increased risk for heart defects specifically.

According to data obtained from the National Birth Defects Prevention Study of infants, women who took an SSRI-antidepressant were more likely than those who were not exposed to have an infant with birth defects.

Birth defects also include  omphalocele (an abnormality in newborns in which the infant’s intestine or other abdominal organs protrude from the navel) or craniosynostosis (connections between sutures-skull bones, prematurely close during the first year of life, which causes an abnormally shaped skull)

Read more about Paxil and birth defects.


Do you have a Paxil claim?

If you or a loved one has a child born with Paxil birth defects, you may have a claim against the drug manufacturer.

Please contact our Paxil attorneys today by filling out the brief questionnaire, or by calling our toll free number (1-800-898-2034) for a free, no-cost no-obligation evaluation of your case.